{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:17:11Z","timestamp":1793848631871,"version":"4.6.1"},"reference-count":8,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T00:00:00Z","timestamp":1208390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:\u2002<\/jats:bold>\n                    To evaluate the association between inhibition of dipeptidyl peptidase (DPP)\u20108 and\/or DPP\u20109 organ toxicities and mortality in rodents.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Research Design and Methods:\u2002<\/jats:bold>\n                    The relative selectivity of the DPP\u20104 inhibitor, vildagliptin, was determined by comparing its\n                    <jats:italic>K<\/jats:italic>\n                    <jats:sub>I<\/jats:sub>\n                    (concentration of compound yielding 50% inhibition of the enzyme) values for inhibition of recombinant human DPP\u20104, DPP\u20108 and DPP\u20109 assessed\n                    <jats:italic>in vitro<\/jats:italic>\n                    . In experiments performed\n                    <jats:italic>in vivo<\/jats:italic>\n                    , vildagliptin was administered by gavage for 13 weeks, at doses up to 1500 mg\/kg\/day in CD\u20101 mice and at doses up to 900 mg\/kg\/day in Wistar rats. Plasma concentrations of vildagliptin were assessed at week 12, and toxicities previously ascribed to inhibition of DPP\u20108 and\/or DPP\u20109 were assessed at week 13.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    The\n                    <jats:italic>K<\/jats:italic>\n                    <jats:sub>I<\/jats:sub>\n                    values for vildagliptin\u2010induced inhibition of DPP\u20104, DPP\u20108 and DPP\u20109 were 3, 810 and 95 nM respectively. The mean plasma concentration 24 h after dose after 12\u2010week daily dosing with 1500 mg\/kg\/day in mice was 2279 nM. The mean plasma drug level 24 h after dose after 12\u2010week daily dosing with 900 mg\/kg\/day in rats was 5729 nM. These high doses maintained plasma drug levels well above the\n                    <jats:italic>K<\/jats:italic>\n                    <jats:sub>I<\/jats:sub>\n                    values for DPP\u20108 and DPP\u20109 throughout a 24\u2010h period. At these high doses, the toxicities of a selective DPP\u20108\/DPP\u20109 inhibitor that were reported previously (100% mortality in mice, alopecia, thrombocytopenia, reticulocytopenia, enlarged lymph nodes, splenomegaly and 20% mortality in rats) were not observed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    Inhibition of DPP\u20108 and DPP\u20109\n                    <jats:italic>per se<\/jats:italic>\n                    does not lead to organ toxicities and mortality in rodents. Thus, a mechanism other than DPP\u20108\/DPP\u20109 inhibition likely underlies the toxicity previously reported to be associated with a selective DPP\u20108\/DPP\u20109 inhibitor.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2008.00860.x","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T06:14:44Z","timestamp":1208412884000},"page":"1057-1061","source":"Crossref","is-referenced-by-count":100,"title":["Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited"],"prefix":"10.1111","volume":"10","author":[{"given":"B. F.","family":"Burkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Hassiepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Trappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Juedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4838(01)00278-3"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0070-2153(03)54010-8"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb17986.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.136.8.7628397"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2005.09.011"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2006.024"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0233"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.10.2988"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2008.00860.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2008.00860.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:26:24Z","timestamp":1761888384000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2008.00860.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,14]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1463-1326.2008.00860.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00860.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,14]]}}}